 |
|
Home | Medifast Stock Price Down 10.2% Following Analyst Downgrade (MED) |
 |
Medifast Stock Price Down 10.2% Following Analyst Downgrade (MED)
|
 |
- August 09, 2014
-
Medifast (NYSE:MED) traded down 10.2% during trading on Friday after Canaccord Genuity lowered their price target on the stock from $32.00 to $29.00, American Banking News.com reports. The stock traded as low as $26.02 and last traded at $26.03, with a volume of 442,420 shares changing hands. The stock had previously closed at $29.00. MED […]This article (Medifast Stock Price Down 10.2% Following Analyst Downgrade (MED)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/08/09/medifast-stock-price-down-10-2-following-analyst-downgrade-med/
|
 |
|
 |
|
 |
